MITF and melanoma: In addition to promoting FA synthesis, a further functional role of MITF in regulating energy metabolism to sustain melanoma proliferation has been observed after treatment with diclofenac and lumiracoxib, two commonly used therapeutic agents that decrease melanoma proliferation by impairing oxidative and glycolytic pathways through MITF downregulation (Brummer et al., 2019).